Liraglutide 3 mg placebo

DRUG5 trials

Sponsors

Henrik Gudbergsen, Parker Research Institute

Conditions

ObesityOsteoarthritisOsteoarthritis, Knee

Phase 4

Liraglutide 3 mg for Knee Osteoarthritis

CompletedNCT02905864

Henrik GudbergsenObesity, Osteoarthritis

Start: 2016-11-30End: 2019-03-31Target: 150Updated: 2019-03-25

Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis

CompletedNCT02910570

Parker Research InstituteOsteoarthritis, Knee

Start: 2016-11-30End: 2019-03-31Target: 150Updated: 2019-03-25

Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance

CompletedNCT02928679

Henrik GudbergsenObesity, Osteoarthritis

Start: 2016-11-30End: 2019-03-20Target: 150Updated: 2019-03-25

Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance

CompletedNCT02928614

Henrik GudbergsenObesity, Osteoarthritis

Start: 2016-11-30End: 2019-03-31Target: 150Updated: 2019-03-25

Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance

CompletedNCT02931383

Henrik GudbergsenObesity, Osteoarthritis

Start: 2016-11-30End: 2019-03-31Target: 150Updated: 2019-03-25

Related Papers

Effect of weight loss and liraglutide on neutrophil gelatinase-associated lipocalin levels among individuals with overweight and knee osteoarthritis: Exploratory analyses of a randomized controlled trial.

2025-01-032 citations

Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial.

2021-02-0173 citations

The impact of a significant weight loss on inflammation assessed on DCE-MRI and static MRI in knee osteoarthritis: a prospective cohort study.

2020-03-1014 citations

Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial

BMJ Open2019-05-0110 citations